ReproCELL Incorporated (TYO:4978)
159.00
-4.00 (-2.45%)
At close: Feb 6, 2026
ReproCELL Employees
ReproCELL had 99 employees as of March 31, 2025. The number of employees increased by 3 or 3.13% compared to the previous year.
Employees
99
Change (1Y)
3
Growth (1Y)
3.13%
Revenue / Employee
26.59M JPY
Profits / Employee
-2.82M JPY
Market Cap
15.06B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 99 | 3 | 3.13% |
| Mar 31, 2024 | 96 | 4 | 4.35% |
| Mar 31, 2023 | 92 | -6 | -6.12% |
| Mar 31, 2022 | 98 | -8 | -7.55% |
| Mar 31, 2021 | 106 | -7 | -6.19% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Japan Tissue Engineering | 204 |
| Immuno-Biological Laboratories | 58 |
| AnGes | 55 |
| StemRIM | 45 |
| Stella Pharma | 43 |
| Kidswell Bio | 37 |
| Nano Holdings | 20 |
| Kubota Pharmaceutical Holdings | 19 |